Life Sciences Ontario Celebrates Excellence and Innovation in Life Sciences with 2025 Awards Announcement

TORONTO–(BUSINESS WIRE)–#innovationleadershipawards–Life Sciences Ontario (LSO) proudly announces the recipients of the 2025 LSO Awards, celebrating excellence and innovation in life sciences. Now in its 22nd year, the LSO Awards continues its longstanding tradition of recognizing outstanding individuals and companies whose contributions have significantly advanced Ontario’s life sciences sector. From research leaders who have advanced scientific … [Read more…]

Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2024

Performance Reflects Progress Toward Delivering Sustained, Top-Tier Growth Fourth Quarter Revenues were $12.3 Billion, Increasing 8% (+9% Adjusting for Foreign Exchange); GAAP Earnings Per Share (EPS) was $0.04 and Non-GAAP EPS was $1.67 Growth Portfolio Revenues were $6.4 Billion, Increasing 21% (+23% Adjusting for Foreign Exchange) Full-Year Revenues were $48.3 Billion, Increasing 7% (+9% Adjusting … [Read more…]

Wyss Center Partners with BrainScape Medical to License Groundbreaking Epios® Technology

GENEVA, Switzerland–(BUSINESS WIRE)–#ai–The Wyss Center for Bio and Neuro Engineering is pleased to announce a strategic partnership with BrainScape Medical, a newly established company specializing in long-term brain monitoring and neurostimulation. This collaboration marks a major step in translating innovative neurotechnology into real-world clinical solutions. The Wyss Center has granted BrainScape Medical an exclusive license … [Read more…]

Proposed Delisting via Merger of BenevolentAI into Osaka Holdings S.à r.l. and Publication of Notice of Extraordinary General Meeting

LONDON–(BUSINESS WIRE)–Regulatory News: BenevolentAI, (“BenevolentAI” or “the Company”) (Euronext Amsterdam: BAI), a pioneer in AI-driven drug discovery, today announces: Subject to shareholder approval, the proposed delisting of BenevolentAI from Euronext Amsterdam N.V. (the “Delisting”) via a merger of the Company into Osaka Holdings S.à r.l. (“Osaka Holdings”), (the “Merger”), which will transition the Company to … [Read more…]

Performant to Participate in the Upcoming BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

PLANTATION, Fla.–(BUSINESS WIRE)–Performant Healthcare, Inc. (Nasdaq: PHLT) (“Performant”), a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, announced today that it will participate in the BTIG at Snowbird: MedTech, Digital Health, Life Science & Diagnostic Tools Conference, on Wednesday, February 12th. Rohit Ramchandani, CFO, will participate in one-on-one investor meetings virtually on … [Read more…]

Turn Therapeutics Achieves 24-Hour Stability for Live Vaccine in Intranasal Oil Suspension at Room Temperature, Marking Major Milestone Toward Improving Vaccine Access

LOS ANGELES–(BUSINESS WIRE)–#TurnTherapeutics–Turn Therapeutics has successfully maintained a live vaccine’s viability for 24 hours at room temperature using its oil suspension technology. This breakthrough — which entailed stabilizing a well-recognized vaccine vector in a viscous oil delivery system — is a step toward making it easier to store, transport, and administer vaccines globally, especially in … [Read more…]

The New England Center for Children Partners with Boston University’s Henry M. Goldman School of Dental Medicine to Provide Dental Care for Students with Autism

SOUTHBOROUGH, Mass.–(BUSINESS WIRE)–The New England Center for Children® (NECC®), a global leader in autism education and research, has partnered with Boston University Henry M. Goldman School of Dental Medicine (GSDM) to deliver dental exams and preventative care for students with autism at NECC’s on-site dental clinic. The Smigel Supersmile® Dental Clinic represents a groundbreaking step … [Read more…]

Miist Therapeutics Announces $7M In Funding to Develop Instant-Acting Medicine

Funding Will Accelerate Miist’s Two Active Programs in Migraine and Smoking Cessation Phase 1 Smoking Cessation Trial Demonstrates Unmatched Speed with 92% Symptom Relief in Only 2 Minutes Scalable Approach and Technology Opens Up Instant Relief for Many Therapeutic Areas ALAMEDA, Calif.–(BUSINESS WIRE)–#HealthTech—Miist Therapeutics, a physics-based developer of inhaled medicines, today announced $7M in seed … [Read more…]

HSS Appoints Mark Bowen, MD Inaugural Medical Advisor, Strategy & Business Development

NEW YORK–(BUSINESS WIRE)–Hospital for Special Surgery (HSS), the world’s leading academic medical center focused on musculoskeletal health, today announced the appointment of renowned surgeon, scientist, educator and leader Mark Bowen, MD, as Medical Advisor, Strategy & Business Development, effective March 1. In this newly created role, Dr. Bowen will serve as a strategic partner to … [Read more…]

Cencora Reports Fiscal 2025 First Quarter Results

Revenue of $81.5 billion for the First Quarter, a 12.8 Percent Increase Year-Over-Year First Quarter GAAP Diluted EPS of $2.50 and Adjusted Diluted EPS of $3.73 Adjusted Diluted EPS Guidance Range Raised to $15.25 to $15.55 for Fiscal 2025 CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 first quarter ended … [Read more…]